Literature DB >> 6657173

Sebaceous adenocarcinoma of the eyelid.

G A Epstein, A M Putterman.   

Abstract

Sebaceous adenocarcinoma is a rare neoplasm of the eyelid that often masquerades as a chalazion, blepharitis, or blepharoconjunctivitis. Controversy exists as to the proper mode of therapy for patients with a tumor confined to the eyelid. We believe that wide local excision (5 to 6 mm of normal tissue) with frozen section analysis and eyelid reconstruction is the preferred treatment. Only 1 of 11 patients had a recurrence with this technique. No regional or distant metastasis has occurred in an average of 68 months of follow-up.

Entities:  

Mesh:

Year:  1983        PMID: 6657173

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Incidence of eyelid cancers in Singapore from 1968 to 1995.

Authors:  S B Lee; S M Saw; K G Au Eong; T K Chan; H P Lee
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Sebaceous Gland Carcinoma of the Lower Eyelid Reconstructed with a Composite Flap: A Case Report.

Authors:  Surya Rao Rao Venkata Mahipathy; Alagar Raja Durairaj; Kanmani Kothandaraman; Vimal Chander Rajamanohar; Aarthi Prabakaran
Journal:  J Clin Diagn Res       Date:  2016-06-01

4.  Sebaceous gland carcinoma of the eyelid.

Authors:  Upender K Wali; Abdullah Al-Mujaini
Journal:  Oman J Ophthalmol       Date:  2010-09

5.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.